Abstract
Objective
To develop imaging guidelines for the MR work-up of female genital tract congenital anomalies (FGTCA).
Methods
These guidelines were prepared based on a questionnaire sent to all members of the European Society of Urogenital Radiology (ESUR) Female Pelvic Imaging Working Group (FPI-WG), critical review of the literature and expert consensus decision.
Results
The returned questionnaires from 17 different institutions have shown reasonable homogeneity of practice. Recommendations with focus on patient preparation and MR protocol are proposed, as these are key to optimised examinations. Details on MR sequences and planning of uterus-orientated sequences are provided.
Conclusions
The multiplanar capabilities and soft tissue resolution of MRI provide superb characterisation of the wide spectrum of findings in FGTCA. A standardised imaging protocol and method of reporting ensures that the salient features are recognised, contributing to a correct diagnosis and classification of FGTCA, associated anomalies and complications. These imaging guidelines are based on current practice among expert radiologists in the field and incorporate up to date information regarding MR protocols and essentials of recently published classification systems.
Key Points
• MRI allows comprehensive evaluation of female genital tract congenital anomalies, in a single examination.
• A dedicated MRI protocol comprises uterus-orientated sequences and vaginal and renal evaluation.
• Integration of classification systems and structured reporting helps in successful communication of the imaging findings.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
The majority of female genital tract congenital anomalies (FGTCA) affect the uterus. However, the spectrum of FGTCA is large, encompassing anomalies of the cervix, vagina, vulvar introitus and fallopian tubes, with or without associated malformations of the ovary, urinary tract, skeleton and other organs [1, 2].
Although the embryology of the female genital tract is complex and still not fully understood, a basic knowledge is important for a better understanding of the pathogenesis of FGTCA and associated anomalies [3].
FGTCA can be comprehensively evaluated with magnetic resonance imaging (MRI) to aid in characterisation of the anomaly and assessment of associated complications and for preoperative planning [4,5,6,7].
Several classification systems have been proposed to describe FGTCA. The most recent was published in 2013 by the European Society of Human Reproduction and Embryology/European Society for Gynaecological Endoscopy (ESHRE/ESGE) [8].
This paper will provide guidance on patient preparation, dedicated MRI protocols and a structured report format to allow for uniform state-of-the-art examination of FGTCA.
Materials and methods
These guidelines were prepared by the Female Pelvic Imaging Working Group (FPI-WG) of the European Society of Urogenital Radiology (ESUR), based on a questionnaire sent to all FPI-WG members, critical review of the literature and expert consensus decision.
Literature review
Published literature was collected through a Medline search of abstracts, from 1 January 2004 to 31 January 2019, including the keywords: ‘Mülllerian duct anomalies’ and ‘MR imaging’.
The results were limited to English language, to full text available and to publications from important radiology, gynaecology and urology journals (impact factor above 1).
Articles were organised in main topics and shared electronically with all authors via Dropbox® (Dropbox Inc.).
Questionnaire
A questionnaire was proposed (C.M.) and then refined by two further authors (N.B., R.F.). The topics addressed include indications, clinical practice, patient preparation, MRI protocol and reporting (including use of classification systems and structured reports). The role of computed tomography (CT) and the clinical practice of 2D/3D gynaecological ultrasound (US) were also assessed.
Data extraction and consensus meeting
ESUR FPI-WG members were invited via email to complete the questionnaire based on local practice. Returned questionnaires were reviewed and data extracted (C.M.). Results were presented and discussed at the FPI-WG meeting at ECR 2019 in Vienna, Austria.
After the meeting, preliminary patient preparation and a detailed MR protocol were developed by the lead authors (C.M., N.B., R.F.). This was sent via email to all those involved in the guideline. Contributions were incorporated and a final version of MR protocol and patient preparation was reached.
Consensus was defined as at least 80% agreement among experts.
Results
Participating institutions
Twenty questionnaires were returned from 17 different institutions: 18 from Europe, 1 from Japan and 1 from the USA:
-
Portugal: n = 4 (2 from the same institution, same protocol)
-
Serbia: n = 3 (from the same institution, same protocol)
-
Italy: n = 2
-
Greece: n = 2
-
UK: n = 2
-
Austria: n = 1
-
France: n = 1
-
Switzerland: n = 1
-
Spain: n = 1
-
Germany: n = 1
-
Japan: n = 1
-
USA: n = 1
The return rate according to the total number of FPI-WG members (n = 57) was 35%. Several FPI-WG members were unable to collaborate, as their practice is mainly oncological imaging, with little or no congenital anomaly work.
MRI exams reported per year
Among respondents, the approximate number of MRI exams performed and/or reviewed per year for assessing FGTCA is the following:
-
Less than 10 exams: n = 7
-
10–20 exams: n = 3
-
20–50 exams: n = 6
-
More than 50 exams: n = 1
Indications for MR imaging of FGTCA
The most common indications for MRI in FGTCA are to clarify imaging findings at gynaecological US (n = 16), hysterosalpingogram (n = 12) or CT (n = 10) (Table 1).
Role of computed tomography
The majority of respondents (82%) did not see any role for CT in assessing FGTCA. Three believe that CT can have a role in selected cases: complementary to MRI to characterise associated renal anomalies or other anomalies in the abdomen, and occasionally as the first imaging modality to suggest the presence of a FGTCA, when the CT is performed for another reason (Fig. 1).
3D ultrasound
None of the responding radiologists performs 3D US for FGTCA themselves; however, it is performed by gynaecologists in several institutions. Only one respondent reported access to 3D US for correlation with MRI.
Patient preparation
In most institutions (n = 15/17; 88% agreement - consensus), the patient is not scheduled according to the menstrual cycle. In the remaining 2 institutions, patients are scheduled in the secretory phase or ‘mid-cycle’.
The majority of respondents (n = 14/17; 83% agreement - consensus) ask the patient clinical questions or ask them to complete a questionnaire before the exam (e.g. time of last menstruation, clinical symptoms, previous gynaecological surgery).
The majority of the institutions (n = 13/17; 77% agreement - no consensus) ask the patient to fast before examinations to reduce artefact from bowel motion. Duration of fast ranges between 2 and 6 h, mostly 4 h (n = 7).
In most institutions (n = 15/17; 88% agreement - consensus), spasmolytic agents are used on a regular basis. Butylscopolamine was the most commonly used (n = 10), while glucagon was used in three institutions (n = 3). In the four remaining institutions, both spasmolytic agents were available. Butylscopolamine was used by intravenous (IV) administration in 6 institutions and by intramuscular (IM) administration in other 6 institutions. Glucagon was used by IV administration in 3 institutions and by IM administration in 4 institutions.
Patients should achieve a moderately distended urinary bladder. This is usually achieved by instructing the patient to empty their bladder 1 h prior to the examination (n = 17/17; 100% agreement - consensus).
In 9 institutions, vaginal opacification with US gel is performed (n = 9/17, 53% agreement), routinely (n = 3/17) or in selected cases (n = 6/17). In 8 institutions, vaginal opacification is not performed (no consensus).
Gel instillation was performed by a nurse, radiology technician, radiologist or the patient themselves, according to the local department resources and practices. Indications for vaginal opacification are listed (Table 2).
Patient positioning
Patient positioning is not uniform: supine and head first (n = 8/17) and supine and feet first (n = 9/17). In one institution, head first is routinely used and feet first in cases of severe claustrophobia.
MR equipment
Different MRI scanners (Philips, GE, Siemens) are used, with 1.5-T and 3.0-T magnetic field strength.
In 9 institutions, both 1.5-T and 3.0-T platforms were available. 3.0 T was preferred over 1.5 T in 7 cases; in one case, 1.5 T was preferred over 3.0 T.
A variety of coils are used for imaging, with a preference for pelvic phased array and multi-channel body coils.
MR protocol
Imaging of kidneys is performed routinely in all except one institution (n = 16/17; 94% agreement) using T2 HASTE (coronal (n = 7), axial (n = 4) or both planes (n = 5)).
All protocols include T1W imaging (n = 17/17; 100% agreement). The majority of institutions (n = 14/17 83% agreement) perform T1W imaging without and with fat suppression (FS). T1W without FS only is performed in 3 institutions. T1W sequences used were standard sequences and/or Dixon technique. Overall, Dixon technique is used in 8 institutions. Axial plane was used in all institutions, with one adding the sagittal plane.
All institutions performed multiplanar T2W sequences of the pelvis in strictly axial, sagittal and/or coronal orientation (n = 17/17, 100% agreement), in two (n = 7/17) or three planes (n = 7/17), with only one plane in three institutions (n = 3/17). All except one institution also performed uterus-orientated T2W sequences (n = 16/17, 94% agreement).
T2W uterus-orientated sequences most commonly obtained were a combination of true coronal and true axial of the uterus fundus and body (n = 13/17, 76% agreement). T2W true axial of the cervix was obtained in 7 institutions (n = 7/17, 42% agreement).
One institution obtains T2W parasagittal sequence, planned to get in the same alignment of the uterus and the cervix, whenever there is a significant lateral deviation of uterine body and fundus relative to the cervix.
3D-T2W sequence of the pelvis, allowing multiplanar reformatting (MPR) of the uterus, is used in 2 institutions. A further 2 respondents remarked that they have trialled this sequence but found image quality to be low.
Three institutions use IV gadolinium for characterisation of FGTCA routinely, 8 depending on the clinical question and findings on pre-contrast sequences and the remaining 6 institutions do not use gadolinium. Indications for IV gadolinium include evaluation of concomitant findings (ovarian or myometrial masses, endometrial polyps), suspicion of abscess/infection or after treatment (e.g. metroplasty). MR-urography is added in cases of urinary tract obstruction at one institution.
Reporting
Standardised proforma reporting is only performed at 3 institutions (n = 3/17).
In the MRI report, all (n = 17/17) include the following: size and morphology of the uterus, cervix and ovaries, ovarian position and associated findings (such as endometriosis, adhesions, and bone anomalies). Almost all (n = 15/17) give details on the vagina (size, morphology) and kidneys.
Other information that might be included is clinical information from the questionnaire, pelvic fluid, lymph nodes and any other anomaly detected (in liver, bowel).
Almost all respondents apply a classification system for FGTCA (n = 15/17), with distribution detailed in Supplementary Material Table 1.
Clinical meeting
Six institutions discuss the imaging of FGTCA cases in multidisciplinary meetings.
Discussion
Patient preparation
Patient preparation is summarised in Table 3.
Scheduling
Scheduling of MRI examination according to the menstrual cycle is not necessary. This agrees with the majority of authors in the literature [9].
Clinical questionnaire
It is recommended to obtain specific clinical information at the time of the scan: date of last menstruation, clinical symptoms and previous gynaecological surgery.
Fasting and spasmolytic agents
In line with previous ESUR guidelines [9,10,11], it is recommended to fast before the examination (3–6 h) and to administer spasmolytic agents (20 mg of butylscopolamine or 1 mg glucagon (IV/IM), unless contraindicated) to reduce bowel motion artefact and obtain high-quality MR imaging.
Bladder
It is recommended to achieve a moderately filled bladder, in line with previous ESUR guidelines [9,10,11].
Vaginal gel
Vaginal opacification with gel can be useful in the assessment of vaginal anomalies, which are often overlooked in the absence of appropriate vaginal distension (Fig. 2a) [12, 13].
The use of intracavitary gel facilitates identification and characterisation of a vaginal septum, both transverse and longitudinal, on T2W sequences (Fig. 3) [14]. In addition, it helps to evaluate partial vaginal agenesis or segmental vaginal atresia before the surgical treatment [15].
The visualisation of vaginal/vulvar cysts is simplified and that of cervix/double cervix may also be improved (Fig. 2b) [15].
Vaginal filling is inexpensive and well tolerated [16]. Self-application of gel by the patient, when feasible, is a good strategy to overcome religious and personal issues, regarding vaginal manipulation. Additionally, it has the advantage not to overload the radiology staff when availability of time is limited.
A consensus was not reached among the respondents regarding vaginal gel use.
MRI protocol
In the study of FGTCA, the MRI protocol is based on the use of multiplanar 2D T2W high-resolution TSE/FSE sequences. T2W images require a slice thickness ≤ 4 mm with high matrix (512 × 512) and a small FOV to obtain a higher spatial resolution (Fig. 4a, b). Fat suppression is not recommended, due to the inherent contrast between the signal intensity of the uterus and the surrounding fat.
Multiplanar imaging is mandatory, and dedicated planes should be obtained along the long and short axis of the uterine body (yielding true coronal and true axial images of the uterus) in order to evaluate the external fundal contour and the cavity shape. For the purpose of uterine malformation classification, imaging the uterus in its true coronal plane is the most critical (Fig. 4) [4].
An oblique sequence obtained perpendicular to the cervical canal results in a short-axis view and allows accurate assessment of the cervix, i.e. the diagnosis of duplication or septation [17].
T1W FS sequences are required to detect blood products, in particular to evaluate the presence of haematometra, haematocolpos or endometriosis [5].
A coronal T2W sequence with a large FOV (such as SSFSE) should be acquired to evaluate the presence, position and morphology of the kidneys [18]. Additionally, this sequence can detect ectopic ovaries, which sometimes lie above the pelvic brim, outside the standard field for pelvic assessment, and may be reported as absent (Fig. 5) [19].
Gadolinium-based contrast agent is generally selectively used to assess incidentally detected coexisting conditions [12]. Delayed contrast-enhanced imaging may be useful if anomalous ureteral insertion is suspected [4].
In cases where a complex renal malformation is suspected, it might be useful to complete the examination performing MR-urography sequences.
Newer 3D T2W sequences seem to provide superior image quality and better 3D reconstructions compared with the classic 2D T2W sequences [20] with significant reduction in total scan time, compared with multiple 2D acquisitions [21]. The precise planning of the conventional scanning planes is not required [4] as images can be reformatted in any plane, including curved MPR [22] and double oblique through the uterus [18]. These 3D T2W sequences have different trade names: CUBE (GE), VISTA (Philips), SPACE (Siemens), among others [23].
Several MRI protocols for assessment of FGTCA are described in the literature. An abbreviated MRI protocol consisting of 3D T2W and non-enhanced axial T1W sequences for the pelvis and coronal SSFSE T2W sequences for the abdomen was recently proposed. This short protocol would provide useful information with regard to the uterine structure, the presence of blood products in the uterine cavity and the presence of renal anomalies [24].
The proposed ESUR-MRI protocol intends a dedicated evaluation of FGTCA (Table 4). Consensus was reached among the respondents.
Value of MRI in the evaluation of FGTCA, associated anomalies and complications
Uterus, cervix and vagina
MRI provides detailed information on the uterovaginal anatomy, particularly in the study of the external profile of the uterine fundus and the cavity shape, and it also allows tissue characterisation of the possible septa, thus providing a complete classification of the specific anomaly [22, 25]. Currently, MRI presents the highest diagnostic accuracy in the characterisation of uterine anomalies (nearly 100%), owing to an excellent soft tissue resolution and multiplanar capability [26,27,28].
MRI is more accurate than US in the detection of rudimentary horns and can discriminate a non-functional rudimentary horn from a functional non-communicating rudimentary horn, thanks to its ability to evaluate the zonal anatomy and signal intensity involving the endometrial cavity and the possible presence of haematometra [22, 29].
Kidney and ureter
Uterine anomalies are often associated with urinary tract malformations, as the embryological development of the urinary system is closely associated with that of the genital tract (Fig. 6) [2]. Retrospective studies have demonstrated associated urinary tract anomalies in 17–42% of patients, with unilateral renal agenesis being the most common. Additional renal anomalies include multicystic dysplastic kidney, pelvic kidney, duplex kidney, horseshoe kidney and renal malrotation [30].
Patients with unilateral renal agenesis may have lower ureteric remnants inserting ectopically into the vagina, cervix and perineum, and distended with blood. Ectopic ureters have also been reported, with an apparently higher incidence compared with the general population [7]. Accurate knowledge of the ureteric course, presence of ectopic ureter or ureteric remnant, may be important preoperative information [7].
Ovaries
Ovarian maldescent is defined as lack of normal descent of the ovary during the embryonic development. Ovaries may be found in an ectopic position along the migration pathway from the lumbar region to the ovarian fossa [31].
The incidence of ovarian maldescent is increased in patients with MDA (17%) compared with women with normal uterine morphology (3%) [32].
MRI is considered the best imaging technique in the evaluation of abnormally located ovaries [33, 34]. The limited FOV of transvaginal US can preclude their identification [32].
Musculoskeletal anomalies
Fusion of vertebral bodies, hemivertebra, and malformation of the coccyx and sacral bone, scoliosis, have been reported in Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome [35, 36]. These anomalies can be evaluated within the imaged FOV of MRI examination.
Endometriosis and pelvic adhesions
Endometriosis and pelvic adhesions are potential long-term complications of obstructive anomalies, due to retrograde menstrual flow from the obstructed side. MRI can detect these complications [4, 37, 38].
Classification systems
Several classification systems exist for FGTCA; none of which is currently universally accepted, since all of them present some shortcomings.
In the medical literature, the ASRM classification is most widely used. In our group, the survey showed a slight preference for the ASRM classification over ESHRE/ESGE classification, probably reflecting that the ASRM classification was introduced earlier.
ASRM classification [39] distinguishes 7 different classes considering the Müllerian development and the relationship of the malformations to fertility [1, 4]. It is based mainly on uterine malformations while malformations of the vagina, adnexa or other associated malformations of non-Müllerian origin are not taken into account [40]. Furthermore, more complex type of malformations or obstructive anomalies as a result of cervical and/or vaginal aplasia/dysplasia in the presence of a functional uterus is not considered [41].
The vagina cervix uterus adnexa and associated malformation (VCUAM) classification [40] and the Embryological-Clinical classification proposed by Acien and Acien [1] tried to overcome these limitations, but failed to gain widespread acceptance, probably due to its complexity.
In 2013, the ESHRE/ESGE classification was proposed, based on anatomical considerations (Supplementary Material Fig. 1). Congenital anomalies are classified into 6 main classes, expressing uterine anatomical deviations deriving from the same embryological origin. Cervical and vaginal anomalies are classified in independent supplementary sub-classes. A non-Müllerian duct anomaly, imperforate hymen, is included in sub-class V3, along with transverse vaginal septum [8].
While this most recent classification system has overcome some problems associated with previous systems [41], it was shown in a comparison of the ESHRE-ESGE classification with the ASRM classification using 3D US [42] that the application of the ESHRE-ESGE criteria resulted in a relative overdiagnosis of septate uteri and insufficient inter- and intra-rater reliability [43], which potentially might lead to unnecessary surgical overtreatment.
MR reporting of female genital tract congenital anomalies
The imaging approach can start with assessment of the uterus, cervix and vagina and ovarian location, followed by the evaluation of the kidneys and assessment of complications. Finally, a FGTCA classification system, ideally the same system used by the gynaecologist/surgeon at that institution, should be applied enabling efficient interdisciplinary communication.
A reporting checklist which highlights commonly overlooked imaging features is provided (Table 5).
Conclusion
MRI is a ‘one-stop-shop’ imaging technique for a comprehensive evaluation of FGTCA, encompassing detailed uterovaginal evaluation, identification of abnormally located ovaries, associated anomalies and complications. MRI can also evaluate coexisting pelvic findings, such as leiomyomas, adenomyosis and tubal and ovarian pathologies. Finally, MRI is a non-invasive imaging modality, making it particularly useful in paediatric and virgo intacta patients.
Proper patient preparation and MR protocol are important to provide optimal examinations.
MRI of FGTCA encompasses a variety of imaging findings and the use of classification systems and structured reports can help in efficient transmission of information.
Abbreviations
- ASRM:
-
American Society for Reproductive Medicine
- CT:
-
Computed tomography
- ESHRE/ESGE:
-
European Society of Human Reproduction and Embryology/European Society for Gynaecological Endoscopy
- ESUR:
-
European Society of Urogenital Radiology
- FGTCA:
-
Female genital tract congenital anomalies
- FPI-WG:
-
Female Pelvic Imaging Working Group
- FOV:
-
Field of view
- FS:
-
Fat suppression
- MPR:
-
Multiplanar reformation
- MRI:
-
Magnetic resonance imaging
- MRKH:
-
Mayer-Rokitansky-Küster-Hauser
- SI:
-
Signal intensity
- T1W:
-
T1-weighted
- T2W:
-
T2-weighted
- US:
-
Ultrasound
- VCUAM:
-
Vagina cervix uterus adnexa and associated malformation
References
Acién P, Acién M (2011) The history of female genital tract malformation classifications and proposal of an updated system. Hum Reprod Update 17:693–705
Acién M, Acién P (2014) Normal embryological development of the female genital tract. In: Grimbizis GF et al (eds) Female genital tract congenital malformations: classification, diagnosis and management. Springer-Verlag London
Healey A (2012) Embryology of the female reproductive tract. In: G. Mann et al (eds) Imaging of gynecological disorders in infants and children. Springer-Verlag Berlin Heidelberg
Behr SC, Courtier JL, Qayyum A (2012) Imaging of Müllerian duct anomalies. Radiographics 32:E233–E250
Olpin JD, Moeni A, Willmore RJ, Heilbrun ME (2017) MR imaging of Müllerian fusion anomalies. Magn Reson Imaging Clin N Am 25:563–575
Robbins JB, Parry JP, Guite KM et al (2012) MRI of pregnancy-related issues: Müllerian duct anomalies. AJR Am J Roentgenol 198:302–310
Hall-Craggs MA, Kirkham A, Creighton SM (2013) Renal and urological abnormalities occurring with Müllerian anomalies. J Pediatr Urol 9:27–32
Grimbizis GF, Gordts S, Di Spiezio SA et al (2013) The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Hum Reprod 28:2032–2044
Kubik-Huch RA, Weston M, Nougaret S et al (2018) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol 28:3125–3137
Forstner R, Thomassin-Naggara I, Cunha TM et al (2017) ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol 27:2248–2257
Bazot M, Bharwani N, Huchon et al (2017) European Society Of Urogenital Radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur Radiol 27:2765–2775
Yoo R-E, Cho JY, Kim SY, Kim SH (2015) A systematic approach to the magnetic resonance imaging-based differential diagnosis of congenital Müllerian duct anomalies and their mimics. Abdom Imaging 40:192–206
Marcal L, Nothaft MA, Coelho F, Volpato R, Iyer R (2011) Müllerian duct anomalies: MR imaging. Abdom Imaging 36:756–764
Papaioannou G, Koussidis G, Michala L (2011) Magnetic resonance imaging visualization of a vaginal septum. Fertil Steril 96:1193–1194
Engelaere C, Poncelet E, Durot C, Dohan A, Rousset P, Hoeffel C (2018) Pelvic MRI: is endovaginal or rectal filling needed? Korean J Radiol 19:397–409
Brown MA, Mattrey RF, Stamato S, Sirlin CB (2005) MRI of the female pelvis using vaginal gel. AJR Am J Roentgenol 185:1221–1227
Roos J, Kubik-Huch R. Congenital malformations of the uterus (2010) In: Forstner R, Hamm B (eds) MRI and CT of the female pelvis. Spring-Verlag Berlin Heidelberg
Robbins JB, Broadwell C, Chow LC, Parry JP, Sadowski EA (2015) Müllerian duct anomalies: embryological development, classification and MRI assessment. J Magn Reson Imaging 41:1–12
Hall-Craggs MA, Williams CE, Pattison SH, Kirkham AP, Creighton SM (2013) Mayer-Rokitansky-Küster-Hauser syndrome: diagnosis with MR imaging. Radiology 269:787–792
Agrawal G, Riherd JM, Busse RF, Hinshaw JL, Sadowski EA (2009) Evaluation of uterine anomalies: 3D FRFSE Cube versus standard 2D FRFSE. AJR Am J Roentgenol 193:W558–W562
Proscia N, Jaffe TA, Neville AM, Wang CL, Dale BM, Merkle EM (2010) MRI of the pelvis in women: 3D versus 2D T2-weighted technique. AJR Am J Roentgenol 195:254–259
Fukunaga T, Fujii S, Inoue C et al (2017) The spectrum of imaging appearances of Müllerian duct anomalies: focus on MR imaging. Jpn J Radiol 35:697–706
Li Y, Phelps A, Zapala MA, MacKenzie JD, MacKenzie TC, Courtier J (2016) Magnetic resonance imaging of Müllerian duct anomalies in children. Pediatr Radiol 46:796–805
Canellas R, Rosenkrantz AB, Taouli B et al (2019) Abbreviated MRI protocols for the abdomen. Radiographics 39:744–758
Troiano RN, McCarthy SM (2004) Müllerian duct anomalies: imaging and clinical issues. Radiology 233:19–34
Pan H-X, Liu P, Duan H et al (2018) Using 3D MRI can potentially enhance the ability of trained surgeons to more precisely diagnose Müllerian duct anomalies compared to MR alone. Eur J Obstet Gynecol Reprod Biol 228:313–318
Mueller GC, Hussain HK, Smith YR et al (2007) Müllerian duct anomalies: comparison of MRI diagnosis and clinical diagnosis. AJR Am J Roentgenol 189:1294–1302
Console D, Tamburrini S, Barresi D, Notarangelo L, Bertucci B, Tamburrini O (2001) The value of the MR imaging in the evaluation of Müllerian duct anomalies. Radiol Med 102:226–232
Junqueira BLP, Allen LM, Spitzer RF, Lucco KL, Babyn PS, Doria AS (2009) Müllerian duct anomalies and mimics in children and adolescents: correlative intraoperative assessment with clinical imaging. Radiographics 29:1085–1103
Coleman AD, Arbuckle JL (2018) Advanced imaging for the diagnosis and treatment of coexistent renal and Müllerian abnormalities. Curr Urol Rep 19:89
Forstner R (2010) Ovaries and fallopian tubes: normal findings and anomalies. In: Forstner R, Hamm B (eds) MRI and CT of the female pelvis. Spring-Verlag Berlin Heidelberg
Allen JW, Cardall S, Kittijarukhajorn M, Siegel CL (2012) Incidence of ovarian maldescent in women with Müllerian duct anomalies: evaluation by MRI. AJR Am J Roentgenol 198:W381–W385
Trinidad C, Tardáguila F, Fernández GC, Martínez C, Chávarri E, Rivas I (2004) Ovarian maldescent. Eur Radiol 14:805–808
Wang Y, Lu J, Zhu L et al (2018) Increased incidence of abnormally located ovary in patients with Mayer-Rokitansky-Küster-Hauser syndrome: a retrospective analysis with magnetic resonance imaging. Abdom Radiol (NY) 43:3142–3146
Preibsch H, Rall K, Wietek BM et al (2014) Clinical value of magnetic resonance imaging in patients with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome: diagnosis of associated malformations, uterine rudiments and intrauterine endometrium. Eur Radiol 24:1621–1627
Wang Y, Lu J, Zhu L et al (2017) Evaluation of Mayer-Rokitansky-Küster-Hauser syndrome with magnetic resonance imaging: three patterns of uterine remnants and related anatomical features and clinical settings. Eur Radiol 27:5215–5224
Del Vescovo R, Battisti S, Di Paola et al (2012) Herlyn-Werner-Wunderlich syndrome: MRI findings, radiological guide (two cases and literature review), and differential diagnosis. BMC Med Imaging 9;12:4
Zhang H, Qu H, Ning G et al (2017) MRI in the evaluation of obstructive reproductive tract anomalies in paediatric patients. Clin Radiol 72:612.e7–612.e15
(1988) The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertil Steril 49:944–955
Oppelt P, Renner SP, Brucker S et al (2005) The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations. Fertil Steril 84:1493–1497
Di Spiezio SA, Campo R, Gordts S et al (2015) The comprehensiveness of the ESHRE/ESGE classification of female genital tract congenital anomalies: a systematic review of cases not classified by the AFS system. Hum Reprod 30:1046–1058
Ludwin A, Ludwin I (2015) Comparison of the ESHRE-ESGE and ASRM classifications of Müllerian duct anomalies in everyday practice. Hum Reprod 30:569–580
Ludwin A, Ludwin I, Kudla M, Kottner J (2015) Reliability of the European Society of Human Reproduction and Embryology/European Society for Gynaecological Endoscopy and American Society for Reproductive Medicine classification systems for congenital uterine anomalies detected using three-dimensional ultrasonography. Fertil Steril 104:688–697
Acknowledgements
The authors would like to thank the following ESUR members for participating in the survey: Aki Kido, Kyoto, Japan; Athina C. Tsili, Ioannina, Greece; Benedetta Gui, Rome, Italy; Carolina Lopez, UK; Charis Bourgioti, Athens, Greece; Elisabeth Sadowski, Madison, USA; Marijana Nikolic, Vojvodina, Serbia; Olivera Nikolic, Vojvodina, Serbia; Rita Lucas, Lisboa, Portugal; Sandra Sousa, Lisboa, Portugal; Sanja Stojanovic, Vojvodina, Serbia.
Funding
Open access funding provided by Paracelsus Medical University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Professor Rosemarie Forstner, Salzburg, Austria.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required for this study because no patient-sensitive data were used.
Ethical approval
Institutional Review Board approval was not required because the results are based on a survey only.
Methodology
• Prospective
• Observational
• Multicentre study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 1.87 mb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maciel, C., Bharwani, N., Kubik-Huch, R.A. et al. MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines. Eur Radiol 30, 4272–4283 (2020). https://doi.org/10.1007/s00330-020-06750-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-020-06750-8